Cathie Wood's ARKG Outperforms Other ETFs on Biotech Gains

Cathie Wood's ARK Genomic Revolution ETF (ARKG) is outperforming her other exchange-traded funds, driven by significant gains in its two largest holdings, Twist Bioscience (TWST) and 10x Genomics (TXG). Both companies have seen their stock prices increase nearly sixfold this year, benefiting from the increasing synergy between artificial intelligence and biology.